According to SPER Market Research, the Multiplex Assays Market estimated to reach USD 5.6 billion by 2030 with a CAGR of 7.2%. In an immunoassay known as a multiplex test, numerous analytes, such as proteins and other biomolecules, are measured in a single experiment using magnetic beads. Information on many analytes for biological processes is provided by multiplex assay. This aids medical professionals in diagnosing an illness and staging its evolution.
In terms of identification speed and detection precision, multiplex tests outperform singleplex assays. The biomolecules can be detected using a multiplex test at lower reagent and analyte concentrations.
Global Multiplex Assays Market Overview (2022-2030)
- Forecast CAGR (2022-2030): 5.6%
- Forecast Market Size (2030): 7.2 billion
By market share, the market for consumables is the largest product & service sector. The significant market share of this sector is primarily attributed to expanding R&D spending as well as rising assay and reagent use. Due to the rising incidence of chronic illnesses, cancers, and neurodegenerative disorders, high R&D expenditures, the presence of a robust pharmaceutical and biotechnology sector, and the rising adoption of technologically advanced products, North America dominated the market by regional segmentation.
Impact of COVID-19 on the Multiple Assays Market
Multiplex assay market has grown significantly during the COVID-19 pandemic. Multiplex assays have been utilized for the diagnosis of SARS-CoV-2. The regulatory approvals were also relaxed to fasten the manufacturing and availability in the market to meet elevated demand. Temporary operational challenges were observed due to lockdowns. Overall, a positive impact is being observed with relaxation in travelling restrictions and rising demand for diagnosis purpose.
Request For Free sample report @ https://www.sperresearch.com/report-store/Multiplex-Assays.aspx?sample=1
Global Multiple Assays Market Key Segments Covered
The SPER Market Research report seeks to give market dynamics, demand, and supply forecasts for the years up to 2030. This report contains statistics on product type segment growth estimates and forecasts.
Multiple Assays Market by Product & Service:
- Consumables
- Instruments
- Software and Service
Multiple Assays Market by Type:
- Protein Multiplex Assays
- Nucleic Acid Multiplex Assays
- Cell-Based Multiplex Assays
Multiple Assays Market by Technology:
- Flow Cytometry
- Fluorescence Detection
- Luminescence
- Multiplex Real-Time PCR
- Other Technologies
Multiple Assays Market by Application:
- Research & Development
- Clinical Diagnostics
- Other Diseases
Multiple Assays Market by End User:
- Pharmaceutical & Biotechnology Companies
- Hospitals & Research Institutes
- Reference Laboratories
- Others
Multiple Assays Market by Region:
- North America
- Europe
- Asia-Pacific
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends, and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Global Multiplex Assays Market Key Players:
The global multiplex assays market study provides market data by competitive landscape, revenue analysis, market segments and detailed analysis of key market players such as Abcam plc, Agilent Technologies, Inc., Antigenix America, Inc., AYOXXA Biosystems GmbH, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Boster Biological Technology, Cayman Chemical Company, DiaSorin S.p.A., Enzo Life Sciences, Inc., Illumina, Inc, Luminex Corporation, Merck KGaA, Meso Scale Diagnostics Olink, PerkinElmer, Inc., Promega Corporation, Qiagen N.V., Quanterix, Randox Laboratories, Seegene, Shimadzu Biotech, Siemens Healthineers, Thermo Fisher Scientific inc.
Contact Us:
SPER Market Research
Lucia Jones, Business Consultant – U.S.A.
+1-347-460-2899
